TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY

Objective: to study the time course of changes in laboratory biomarkers in patients with rheumatoid arthritis (RA) 2, 4, and 8 weeks after the initiation of tocilizumab (TCZ) therapy. Subjects and methods. Forty-two RA patients receiving two intravenous infusions of TCZ (8 mg/kg each) at a 4-week in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: E N Aleksandrova, E Yu Panasyuk, A S Avdeyeva, A A Novikov, G V Lukina, M V Cherkasova, N V Klimova, E L Nasonov
Format: Artigo
Jezik:Russo
Izdano: IMA-PRESS LLC 2011-06-01
Serija:Научно-практическая ревматология
Teme:
rheumatoid arthritis, interleukin-6
interleukin-6 receptors
tocilizumab, erythrocyte sedimentation rate
c-reactive protein, igm/iga rheumatoid factor
anti-cyclic citrullinated peptide antibodies
anti-modified citrullinated vimentin antibodies
Online pristup:https://rsp.mediar-press.net/rsp/article/view/705
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items